Special Interest Sessions

2023 ASH Guideline Implementation Champions

Sunday, December 10, 2023, 9:30 a.m. - 11:00 a.m.
San Diego Convention Center, Room 7

This session, led by Drs. Rachel Rosovsky and Amy Billett, recognizes practitioners who have been working to implement recommendations for evidence-based guidelines at the point of care in their clinical settings. Each year, a few individuals are selected from a pool of applicants to present their strategies for successful implementation.   

Co-Chairs:

Rachel P. Rosovsky, MD
Massachusetts General Hospital
Boston, MA

Amy L Billett, MD
Dana-Farber Cancer Institute, Inc.
Wilmington, DE

Speakers:

Christina Marie Ruiz, MD
University of California San Diego School of Medicine
San Diego, CA
Improving the Outpatient Pain Management Plan for Patients with Sickle Cell Disease with Innovative Pain Action Plan

Gabriella Nguyen, MD
University of Texas Southwestern
Dallas, TX
Steering Change with COMPASS: Clinical Pathway to Optimize the Management of Pediatric Acute Stroke in Sickle Cell Disease

back to top

AI in Hematology: Where Do You Stand in 2023?

Monday, December 11, 2023, 10:30 a.m. - 12:00 p.m.
San Diego Convention Center, Room 11

Few new tools are attributed with as much potential, disruptive energy, and opportunities for use or abuse as the recent developments in the field of artificial intelligence (AI). These are challenges we must confront in both our personal and professional lives. Particularly in the field of medicine, where our obligation to research and act for the well-being of our patients is paramount, the potential use of AI is also of fundamental importance. The session compiled here will therefore shed light on various aspects from experts. This includes existing possibilities, such as the use of AI in radiological diagnostics. We will discuss its potential to enhance drug discovery, and safety assessments, and develop new medications. Additionally, we want to explore the extent to which AI is already being used or can be used in the near future in the Hematology Clinic, for diagnostics and therapy decisions. The entire discussion will be framed within the context of all aforementioned topics, when addressing urgent ethical issues, to provide knowledge for critical evaluation of how to apply AI in medicine today.

Chair:

Torsten Haferlach, MD,PhD
MLL Munich Leukemia Laboratory
Munich, Germany

Speakers:

Weida Tong, Ph.D.
National Center for Toxicological Research (USFDA)
Jefferson, AR
Can AI Be Used in Drug Discovery?

Yates Coley, PhD
Kaiser Permanente Washington Health Research Institute
Seattle, 
AI ethics: More Complex Than What You Think

Torsten Haferlach, MD,PhD
MLL Munich Leukemia Laboratory
Munich, Germany
The Future Is Now: AI in the Hematology Clinic

back to top

ASH and the ASH Research Collaborative: Advancing Progress in Sickle Cell Disease (for in-person participants)

Monday, December 11, 2023, 6:15 p.m. - 8:00 p.m.
San Diego Convention Center, Room 28 A-D & Plaza Terrace

Meeting attendees with an interest in sickle cell are invited to this reception, which will celebrate progress in sickle cell and provide an opportunity to network.  Through the Sickle Cell Disease (SCD) Initiative, ASH and the ASH Research Collaborative (ASH RC) have made significant progress in 2023 to support advances in research, improving provider training and education, advocating for policies to expand access to care, and enhancing data collection.  The program will feature Dr. Mohandas Narla, ASH President-Elect, and Dr. Alexis Thompson, Chair of the ASH Research Collaborative SCD Data Hub, and SCD Learning Community Subcommittees, presenting a brief snapshot of the advances the ASH and the ASH RC have made to drive change in sickle cell disease over the past year. The remaining part of the program will provide ample time for networking.

back to top

ASH Choosing Wisely® Campaign: 2023 ASH Choosing Wisely Champions

Monday, December 11, 2023, 12:15 p.m. - 1:15 p.m.
San Diego Convention Center, Room 7

The ASH Choosing Wisely Champions initiative recognizes the efforts of practitioners who have been working to eliminate costly and potentially harmful overuse of tests and procedures. Each year, three individuals are invited to present on successful utilization strategies that they have developed and implemented in their practices, institutions, or hospital systems. This session provides an opportunity for clinicians, administrators, and other medical professionals to learn about projects that can be translated to their own practices.

Chair:

Ming Y Lim, MBBChir
University of Utah
Salt Lake City, UT

Speakers:

Vilmarie Rodriguez, MD
Nationwide Children's Hospital/The Ohio State University
Columbus, OH
Rebida: Reduction of Blood Transfusions for Iron Deficiency Anemia

Alessandra Ferrajoli, MD
The University of Texas MD Anderson Cancer Center
Houston, TX
Usefulness of a Treatment Algorithm for the Management of Abnormal Uterine Bleeding in Patients with Hematological Malignancies

Ayman Alhejazi, MD
Ministry of National Guard Health Affairs
Riyadh, SAU
Outpatient Versus Inpatient Delivery of Intensive Chemotherapy for Patients with Hematological Neoplasms: A 5-Year Experience from a Tertiary Center

back to top

ASH Clinicians in Practice (ACIP) Lunch - How Can We Provide Sustainable Care to Hematology Patients?

Sunday, December 10, 2023, 11:15 a.m. - 12:30 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom DE

Sustainable care refers to the ability of our healthcare systems to enhance quality of life and improve well-being. Sustainability can include quality improvement tools, such as pathways or artificial intelligence that may help increase access to new treatments while ensuring value-based care.  While this sounds ideal, how is it achievable in hematology? In this session, speakers will address sustainable care in three presentations: Financial Toxicity: How to determine value of hematology treatments for patients; How can artificial intelligence improve the practice of hematology in providing sustainable care; Can guidelines and pathways help determine value of treatments for hematology patients.

Chair:

Chancellor Donald, MD
Tulane University School of Medicine
New Orleans, LA

Speakers:

Aaron Goodman, MD
UCSD Moores Cancer Center
La Jolla, CA
Financial Toxicity: How to Determine Value of Hematology Treatments for Patients?

Shannon C. Walker, MD
Vanderbilt University Medical Center
Nashville, TN
How can Artificial Intelligence Improve the Practice of Hematology in Providing Sustainable Care in Pediatrics?

Benjamin F. Tillman, MD
Vanderbilt University Medical Center
Nashville, TN
How can Artificial Intelligence Improve the Practice of Hematology in Providing Sustainable Care?

David Andorsky, MD
Rocky Mountain Cancer Centers
Boulder, CO
Can Guidelines and Pathways Help Determine Value of Treatments for Hematology Patients?

back to top

ASH Grassroots Network Lunch

Saturday, December 9, 2023, 11:15 a.m. - 12:15 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom DE

This year’s lunch will highlight a case study demonstrating how ASH members and hematology advocates can be involved at the state and local levels to impact change aimed at improving health outcomes. Presenters will share their story about how successful advocacy in California resulted in building and sustaining the California Sickle Cell Data Collection (SCDC) program, which includes grant funding from the Centers for Disease Control and Prevention (CDC) Sickle Cell Disease Data Collection Program, and how they have used data from this program to build a network of comprehensive sickle cell disease care centers throughout the state to improve health care access.

Chair:

Jennifer Holter-Chakrabarty, MD
University of Oklahoma Stephenson Cancer Center
Oklahoma City, OK

Speakers:

Mary Elizabeth Brown
Sickle Cell Disease Foundation
Ontario, CA
A Case Study of Successful Hematology Advocacy: The California Sickle Cell Data Collection (SCDC) Program

Susan Paulukonis, MA, MPH
Tracking California
Oakland, CA
A Case Study of Successful Hematology Advocacy: The California Sickle Cell Data Collection (SCDC) Program

back to top

ASH Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults

Monday, December 11, 2023, 10:30 a.m. - 12:00 p.m.
Manchester Grand Hyatt San Diego, Grand Hall C

This special education session will provide an overview of the upcoming ASH Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults.  In the first talk, Drs. Wendy Stock and Julie Wolfson will preview recommendations for initial therapy in adolescents and young adults with ALL.  In the second talk, Drs. Kristen O'Dwyer and Sumit Gupta will preview recommendations for the management of remission and relapse in adolescents and young adults with ALL.

Chair:

Matthew C. Cheung, MD,MSc
Toronto, ON, Canada

Speakers:

Wendy Stock, MD
The University of Chicago Medical Center
Chicago, IL
Initial Therapy for ALL in Adolescents and Young Adults

Julie Wolfson, MD, MSHS
The University of Alabama at Birmingham
Birmingham, AL
Initial Therapy for ALL in Adolescents and Young Adults

Kristen M. O'Dwyer, MD
University of Rochester
Rochester, NY
Management of Remission and Relapse of ALL in Adolescents and Young Adults

Sumit Gupta, MD, PhD
The Hospital for Sick Children
Toronto, ON, Canada
Management of Remission and Relapse of ALL in Adolescents and Young Adults

back to top

ASH Guidelines on Venous Thromboembolism (VTE): What's New

Monday, December 11, 2023, 4:30 p.m. - 6:00 p.m.
San Diego Convention Center, Room 28 A-D

This special education session will provide clinically-relevant updates to ASH's portfolio of guidelines on VTE, including the following:

• Dr. Saskia Middeldorp will discuss practice-changing recommendations from the recently published ASH Guidelines on Thrombophilia
• Dr. Deborah Siegal will discuss next steps regarding the ASH Guidelines on the Use of Anticoagulation in Patients with COVID-19
• Dr. Suely Rezende will provide updates on the newest adaptations of ASH VTE guidelines for Latin America

Chair:

Adam Cuker, MD, MS
University of Pennsylvania
Philadelphia, PA

Speakers:

Saskia Middeldorp, MD, PhD
Academic Medical Center
Nijmegen, Netherlands
ASH Guidelines on Thrombophilia

Deborah Siegal, MD,MSc
University of Ottawa
Ottawa, ON, Canada
Next Steps for ASH Guidelines on Use of Anticoagulation in Patients with COVID-19

Suely M. Rezende, MD,PhD
Universidade Federal de Minas Gerais
BELO HORIZONTE, AC, Brazil
Updates on Adaptation of ASH VTE Guidelines for Latin America

back to top

ASH Hemostasis and Thrombosis Community Networking Reception (for in-person participants)

Monday, December 11, 2023, 6:00 p.m. - 7:30 p.m.
San Diego Convention Center, East Terrace (Upper Level)

back to top

ASH-FDA Joint Symposium I: Targeted, Gene and Cellular Therapy - Recent Approvals in Non-Malignant Hematology

Monday, December 11, 2023, 10:30 a.m. - 12:00 p.m.
San Diego Convention Center, Room 7

Chair:

Donna A. Whyte-Stewart, MD,MSc
Food and Drug Administration
Silver Spring, MD

Speakers:

Donna A. Whyte-Stewart, MD,MSc
Food and Drug Administration
Silver Spring, MD
Introduction

Najat Bouchkouj, MD
US Food and Drug Administration
Silver Spring, MD
Cellular Therapy and HSCT Mobilizers – Omidubicel-onlv

Donna A. Whyte-Stewart, MD,MSc
Food and Drug Administration
Silver Spring, MD
Cellular Therapy and HSCT Mobilizers – Motixafortide

Navneet Majhail, MD
Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center
Nashville, TN
Clinical Discussant for Transplant

Alison R. Moliterno, MD
Food and Drug Administration
Silver Spring, MD
Momelotinib for Myelofibrosis

Jeanne Palmer, MD
Mayo Clinic - Arizona
Scottsdale, AZ
Clinical Discussant for Myelofibrosis

Nicole Verdun, MD
Food and Drug Administration
Silver Spring, MD
Gene Therapy and Editing

Punam Malik, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Clinical Discussant on Gene Therapy and Editing

Najat Bouchkouj, MD
US Food and Drug Administration
Silver Spring, MD
Discussion Panel

Navneet Majhail, MD
Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center
Nashville, TN
Discussion Panel

Punam Malik, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Discussion Panel

Alison R. Moliterno, MD
Food and Drug Administration
Silver Spring, MD
Discussion Panel

Jeanne Palmer, MD
Mayo Clinic - Arizona
Scottsdale, AZ
Discussion Panel

Nicole Verdun, MD
Food and Drug Administration
Silver Spring, MD
Discussion Panel

Donna A. Whyte-Stewart, MD,MSc
Food and Drug Administration
Silver Spring, MD
Discussion Panel

Panelists:

Najat Bouchkouj, MD
US Food and Drug Administration
Silver Spring, MD

Navneet Majhail, MD
Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center
Nashville, TN

Punam Malik, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH

Alison R. Moliterno, MD
Food and Drug Administration
Silver Spring, MD

Jeanne Palmer, MD
Mayo Clinic - Arizona
Scottsdale, AZ

Nicole Verdun, MD
Food and Drug Administration
Silver Spring, MD

back to top

ASH-FDA Joint Symposium II: Striking a Balance - Benefit-Risk in Drug Approvals

Monday, December 11, 2023, 2:45 p.m. - 4:15 p.m.
Marriott Marquis San Diego Marina, Marriott Grand Ballroom 5-6

Chair:

Cara Rabik, MD,PhD
Food and Drug Administration
Silver Spring, MD

Speakers:

Cara Rabik, MD,PhD
Food and Drug Administration
Silver Spring, MD
Introduction

Nicole Sunseri, MD,PhD
Food and Drug Administration
Silver Spring, MD
Regulatory Considerations - Recent Approvals of Bispecific T Cell Engagers for Lymphoma - Epcoritamab-bysp and Glofitamab-gxbm

Nicole Sunseri, MD,PhD
Food and Drug Administration
Silver Spring, MD
Regulatory Considerations - Recent Approvals of Bispecific T Cell Engagers for Multiple Myeloma - Talquetamab-tgvs and Elranatamab-bcmm

Jeff P. Sharman, MD
Willamette Valley Cancer Institute and Research Center
Eugene, OR
Clinical Discussant for Lymphoid Malignancies

Joseph Wynne, MD,PhD
Food and Drug Administration
Silver Spring, MD
Quizartinib for Acute Myeloid Leukemia

Alice Mims, MD
Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center
Columbus, OH
Clinical Discussant for Acute Myeloid Leukemia

Margret Merino, MD
Food and Drug Administration
Silver Spring, MD
Overall Survival: Striking a Balance - Benefit-Risk in Drug Approvals

Angelo De Claro, MD
Food and Drug Administration
Silver Spring, MD
Panel Discussion

Nicole Gormley, MD
US Food and Drug Administration
Bethesda, MD
Panel Discussion

Bindu Kanapuru, MD
US Food and Drug Administration
Silver Spring, MD
Panel Discussion

Margret Merino, MD
Food and Drug Administration
Silver Spring, MD
Panel Discussion

Alice Mims, MD
Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center
Columbus, OH
Panel Discussion

Kelly J Norsworthy, MD
Food and Drug Administration
Silver Spring, MD
Panel Discussion

Cara Rabik, MD,PhD
Food and Drug Administration
Silver Spring, MD
Panel Discussion

Nicholas Richardson, DO, MPH
US Food and Drug Administration
Silver Spring, MD
Panel Discussion

Jeff P. Sharman, MD
Willamette Valley Cancer Institute and Research Center
Eugene, OR
Panel Discussion

Nicole Sunseri, MD,PhD
Food and Drug Administration
Silver Spring, MD
Panel Discussion

Joseph Wynne, MD,PhD
Food and Drug Administration
Silver Spring, MD
Panel Discussion

Panelists:

Angelo De Claro, MD
Food and Drug Administration
Silver Spring, MD

Nicole Gormley, MD
US Food and Drug Administration
Bethesda, MD

Bindu Kanapuru, MD
US Food and Drug Administration
Silver Spring, MD

Margret Merino, MD
Food and Drug Administration
Silver Spring, MD

Alice Mims, MD
Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center
Columbus, OH

Kelly J Norsworthy, MD
Food and Drug Administration
Silver Spring, MD

Nicholas Richardson, DO, MPH
US Food and Drug Administration
Silver Spring, MD

Jeff P. Sharman, MD
Willamette Valley Cancer Institute and Research Center
Eugene, OR

Nicole Sunseri, MD,PhD
Food and Drug Administration
Silver Spring, MD

Joseph Wynne, MD,PhD
Food and Drug Administration
Silver Spring, MD

back to top

Blood Advances Presents: How to Peer Review a Scientific Paper

Sunday, December 10, 2023, 11:15 a.m. - 12:15 p.m.
San Diego Convention Center, Room 24

The Blood Advances Editor-in-Chief Dr. Catherine Bollard and Deputy Editor Dr. Andrew Weyrich will lead a panel discussion on How to Peer Review a Scientific Paper. The session will provide valuable information on the best practices of peer review from the editorial perspective for both basic and clinically relevant manuscripts. There are multiple professional benefits to becoming a reviewer. It allows the hematologist to stay current on research and developments in the field and can help in patient care, in the lab, and in the classroom. It also has the additional benefits of allowing the reviewer to be recognized by their colleagues, and the reviewer can use the experience to demonstrate professional development with their institution.

Panelists:

Catherine M. Bollard, MD
Children’s National Hospital
Washington, DC

Andrew S. Weyrich, PhD
Oklahoma Medical Research Foundation
Oklahoma City, OK

back to top

Blood and Beyond

Un-walling Health and Well-Being: Shared destinies at the San Diego-Tijuana Border

Sunday, December 10, 2023, 4:30 p.m. - 6:00 p.m.
San Diego Convention Center, Room 24

The editors of the Blood journal will highlight the intersection of hematology and the humanities in a session entitled Blood & Beyond. For this year, in complement to the celebration of the 20^th anniversary of ASH’s Minority Recruitment Initiative, the session: Un-walling Health and Well-Being: Shared Destinies at the San Diego-Tijuana Border will be presented by Teddy Cruz and Fonna Forman and will consider the intersection of diversity, equity and inclusion, migration, and social policy. Fonna Forman and Teddy Cruz will discuss the eco-social impacts of increasing migration across the US-Mexico border region, and how the UCSD Center on Global Justice is responding to the challenge in Tijuana. This includes the construction of emergency housing, and the coordination of education, vocational training, employment, cultural activity, and health services. 

Teddy Cruz and Fonna Forman are principals in Estudio Teddy Cruz + Fonna Forman, a research-based political and architectural practice in San Diego, CA, transgressing conventional boundaries between theory and practice and merging the fields of architecture and urbanism, political theory, and urban policy. The practice investigates issues of informal urbanization, civic infrastructure, and public culture, with a special emphasis on Latin American cities. Cruz and Forman lead a variety of urban research agendas and civic/public interventions in the San Diego-Tijuana border region, and beyond. From 2012-13, they served as special advisors on civic and urban initiatives for the City of San Diego and led the development of its Civic Innovation Lab. Together, they lead the UCSD Community Stations, a platform for community-engaged research and teaching on poverty and social equity in the border region.

Co-Chairs:

Nancy Berliner, MD
Brigham and Women's Hospital
Boston, MA

Alison R. Walker, MD, MPH, MBA
Moffitt Cancer Center
Tampa, FL

Speakers:

Teddy Cruz, MDes
Estudio Teddy Cruz + Fonna Forman
San Diego, CA
Un-walling Health and Well-Being: Shared destinies at the San Diego-Tijuana Border

Fonna Forman, PhD
Estudio Teddy Cruz + Fonna Forman
San Diego, CA
Un-walling Health and Well-Being: Shared destinies at the San Diego-Tijuana Border

back to top

Blood Presents: How to get Published in a Peer Review Journal

Saturday, December 9, 2023, 11:15 a.m. - 12:15 p.m.
San Diego Convention Center, Room 24

The ability to communicate one’s work effectively by publication in high-impact journals is a benchmark for success in academic medicine. Dr. Nancy Berliner, Editor-in-Chief, and Dr. Andrew Roberts, Deputy Editor, will present information on how to navigate the publication process from the perspective of an author. This panel will provide insight into the elements of a high-quality manuscript worthy of publication in Blood and tips on avoiding common errors that might result in rejection.

Panelists:

Nancy Berliner, MD
Brigham and Women's Hospital
Boston, MA

Andrew W. Roberts, MBBS, PhD
The Walter and Eliza Hall Institute of Medical Research
Melbourne, Australia

back to top

Health Equity Rounds Lunch (for in-person participants)

Sunday, December 10, 2023, 11:15 a.m. - 12:15 p.m.
Hilton San Diego Bayfront, Sapphire Ballroom CD

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.

Moderator:

Yvonne Adeduni Efebera, MD, MPH
OhioHealth
Columbus, OH

back to top

Junior Faculty Career Development Session

Monday, December 11, 2023, 10:30 a.m. - 12:00 p.m.
San Diego Convention Center, Room 25

This education session is designed for junior faculty to discuss career development skills that aren’t typically taught during fellowship. This year’s theme is "How to Get Funding for your Work" and will cover early career topics such as how to fund scholarly work and medical education research presented by a panel of esteemed faculty. The first speaker will provide introductory remarks and then serve as moderator for panel discussion which will review how to strengthen individual career development awards applications such as K23, K08, and K07 awards.

Chair:

Sanjay Mohan, MD, MSCI
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Nashville, TN

Speakers:

Oyebimpe Adesina, MD,MS
University of California
Davis, CA
Individual Career Development Awards- K23/K08

Cassandra Dorothy Josephson, MD
Johns Hopkins University School of Medicine and JH All Children's Hospital
St. Petersburg, FL
Individual Career Development Awards- K07

Srinivas Devarakonda, MD
The Ohio State University
Columbus, OH
Funding Your Medical Education Research

back to top

Maternal Health: Fertility Preservation in Hematology Care

Sunday, December 10, 2023, 9:30 a.m. - 11:00 a.m.
San Diego Convention Center, Ballroom 20AB

Both patients with hematologic conditions and their hematologists face a complex set of challenges when considering options for fertility preservation. With new technologies available and a broader understanding of the need for fertility preservation, there are more opportunities available. This session will explore why there has been such a marked increase in demand for these options, what exactly the options and techniques available are and what both hematologists and their patients need to expect in success rates, complications and demands on their already busy schedules.

Chair:

Sarah O'Brien, MD,MSc
Nationwide Children's Hospital
Columbus, OH

Speakers:

Erica Marsh, MD, MSCI, FACOG
University of Michigan
Ann Arbor, MI
Fertility Health Equity and the Fertility Preservation Process

Alison Loren, MD, MSCE
University of Pennsylvania
Philadelphia, PA
Fertility Care for Patients with Hematologic Conditions

Mindy Christianson, MD, MBA
Cleveland Clinic
Cleveland, OH
Fertility Care for Physicians

back to top

Medical Educators Symposium

Sunday, December 10, 2023, 7:30 a.m. - 9:30 a.m.
Hilton San Diego Bayfront, Sapphire Ballroom AB

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with an hour of general sessions focused on medical education principles and then followed by simultaneous breakout sessions that happen twice.

Chair:

Pallawi Torka, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Speakers:

Angela C Weyand, MD
University of Michigan Medical School
Ann Arbor, MI
General Session 1: Utilizing Social Media in Learning

Alfred I Lee, MD, PhD
Yale University School of Medicine - Yale Cancer Center
New Haven, CT
General Session 2: Making the Most of Virtual Teaching

Scott Moerdler, MD
Rutgers Cancer Institute
New Brunswick, NJ
General Session 2: Making the Most of Virtual Teaching

Alex A Boucher, MD
University of Minnesota
Minneapolis, MN
General Session 3: Diversity, Equity, and Inclusion in Educational Material Development

Erin G Reid, MD, MS
University of California, San Diego
La Jolla, CA
Breakout 1: Technology and Medical Education: Remote Learning

Rita Paschal, MD
University of Alabama At Birmingham Medical Center
Birmingham, AL
Breakout 2: How to be a Good Mentor

Alex A Boucher, MD
University of Minnesota
Minneapolis, MN
Breakout 3: DEI and Implicit Bias in Case Development

Ariela L. Marshall, MD
University of Minnesota
Minneapolis, MN
Breakout 4: Teaching Across the Learner Spectrum and Integrating APPs

Alice Ma, MD
University of North Carolina at Chapel Hill
Chapel Hill, NC
Breakout 5: Giving Good Feedback to Trainees

back to top

Promoting Minorites in Hematology (PMH) MRI Anniversary Reception (for in-person participants)

Saturday, December 9, 2023, 8:00 p.m. - 9:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom G

This year’s reception will commemorate the 20th Anniversary of the Minority Recruitment Initiative (MRI). Join us for the celebration following the oral presentations.

back to top

Promoting Minorities in Hematology (PMH) Oral Presentations: Room I (for in-person participants)

Saturday, December 9, 2023, 6:30 p.m. - 8:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom D

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants.

A special reception celebrating the 20th anniversary of the Minority Recruitment Initiative (MRI) will follow presentations.

Speakers:

Ayo S Falade, MD, MBA
Mass General Brigham Salem Hospital
Salem, MA
Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and without Pre-Transplant Exposure to Novel Agents

Bianca A Ulloa, PhD
Albert Einstein College of Medicine
Bronx, NY
Pre-Clinical Developmental Hematopoiesis Cross-Species Comparative Analysis with KMT2A-Rearranged Infant Acute Lymphoblastic Leukemic Populations

Carla Barrientos Risso
Ponce Health Sciences University
Ponce, Puerto Rico
Discovering Mechanisms of Noncovalent BTK Inhibitor Resistance in CLL

Dailia B. Francis, MD,PhD
Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta
Atlanta, GA
The Immune Checkpoint Siglec-15 in Promoting Immune Dysregulation in Non-Hodgkin Lymphomas

Danielle Sohai
Children's National Hospital
Washington, DC
Expansion of KSHV-Specific T Cells for the Treatment of KSHV-Associated Malignancy

H. Moses Murdock, MD
Dana-Farber Cancer Institute
Boston, MA
Molecular MRD in a Phase 1 Study of Maintenance Azacitidine/Venetoclax after RIC-Ven Allogeneic HSCT in High Risk Myeloid Malignancies

K. Ashley Lyttle
Meharry Medical College
Nashville, TN
GPATCH8 As a Modulator of Mutant SF3B1

Marcus Alexander Florez, PhD
Baylor College of Medicine
Houston, TX
Exploring the Underlying Mechanisms of BST2 in Hematopoietic Stem Cell Activation

Maria J. Fernandez Turizo, MD
Beth Israel Deaconess Medical Center, Harvard Medical School
Brookline, MA
Novel Causal Inference Method Estimates Treatment Effects in a Global Cohort of Patients with Relapsed and Refractory Mature T-Cell and NK-Cell Neoplasms

Omonike Oyelola
University of Connecticut School of Medicine
Farmington, CT
Assessing Disease-Specific Alterations within the Bone Marrow Microenvironment in JAK2 Dependent Neoplasms

Tre Artis
Harvard University
Cambridge, MA
Phenotypic and Molecular Consequences of Noncoding TET2 Perturbations in the Human Hematopoietic System

back to top

Promoting Minorities in Hematology (PMH) Oral Presentations: Room II (for in-person participants)

Saturday, December 9, 2023, 6:30 p.m. - 8:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom E

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants.

A special reception celebrating the 20th anniversary of the Minority Recruitment Initiative (MRI) will follow presentations.

Speakers:

Abdi Abud
University of Missouri-Columbia School of Medicine
Saint Louis, MO
Validation of a Natural Language Processing Tool for Identification of Acute Deep Venous Thrombosis

Andres Felipe Fajardo, MD
McMaster University
Hamilton, ON, CAN
Intellectual Disability, Cancer, and Delayed Diagnosis: A Scoping Review

Elizabeth Rodriguez
The University of Texas Health Science Center at Houston
Houston, TX
Investigating the Impact of Neighborhood Deprivation Level on Late-Term Outcomes in Adolescent and Young Adult Hodgkin Lymphoma Survivors

Elyse Lopez, MD
Baylor College of Medicine
Houston, TX
Health Disparities in Acute Lymphoblastic Leukemia (ALL): A Focus on Adolescent and Young (AYA) Adult Patients and Temporal Trends over Ten Years

Jamie A.G. Hamilton, PhD
Emory University
Atlanta, GA
Delineating How Obesity-Associated Chronic Inflammation Impacts B-Cell Acute Lymphoblastic Leukemia (B-ALL) Progression

Jorge David Avila, MD
St. Elizabeth's Medical Center
Boston, MA
Marital Status, Frailty, and Survival in Older Adults with Blood Cancer

Josue Marquez-Garcia
The Warren Alpert Medical School of Brown University
Arlington, MA
Assessing the Risk of Venous Thromboembolism and Bleeding Among Patients with Myeloproliferative Neoplasms Undergoing Total Knee and Hip Arthroplasty

Maria D. Leon-Camarena, MD
Dell Medical School at University of Texas
Austin, TX
Association of Latino Ethnicity with Cytogenetic Subtype in Pediatric Acute Lymphoblastic Leukemia: A Report from the Reducing Ethnic Disparities in Acute

Oluwalonimi Adebowale, MD
Howard University College of Medicine
Washington, DC
Biomarker, Cytokine and Gene Expression Signatures of Alloimmunization in Children with Sickle Cell Disease

Omolegho Momoh, MD
Montefiore New Rochelle Hospital
New Rochelle, NY
Defining the Clinical Outcomes and Molecular Landscape of Acute Myeloid Leukemia (AML) in Nigeria

Tolulope Rosanwo, MD
Boston Children's Hospital
Boston, MA
Approaches to Evaluate HbF Determinants in Genome Editing for Sickle Cell Disease

back to top

Promoting Minorities in Hematology (PMH) Oral Presentations: Room III (for in-person participants)

Saturday, December 9, 2023, 6:30 p.m. - 8:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom F

ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants.

A special reception celebrating the 20th anniversary of the Minority Recruitment Initiative (MRI) will follow presentations.

Speakers:

Alexis Rae Williams, MD
Boston Children's Hospital
Boston, MA
A Standardized Approach to Screening for Academic Challenges Among Patients with Sickle Cell Disease

Ashley Inez Thrower, BS
Duke University Medical Center
Durham, NC
COVID-19 Vaccination Hesitancy in Adults with Sickle Cell Disease?

Bria Carrithers, MD
University of Alabama at Birmingham
Birmingham, AL
Addressing Reproductive Education Among Young Adults with Sickle Cell Disease (SCD): Sickle Cell Reproductive Outreach and Education (ROE) Project

Emmanuella Oyogoa, DO
Oregon Health and Science University
Portland, OR
Clinical Outcomes of Patients Referred for Asymptomatic Neutropenia: A Focus on Racial Disparities in Hematology

Gabriela Ramirez Cuebas, MD
University of Puerto Rico School of Medicine
San Juan, PR
Assessing Primary Stroke Prevention Barriers and Facilitators in Children with Sickle Cell Anemia in Puerto Rico: A Mixed-Methods Study Design

Ijele Adimora, MD, MBA
The Johns Hopkins University School of Medicine
Baltimore, MD
Neighborhood Disadvantage Increases Risk of Adverse Clinical Events in Children with Sickle Cell Disease

Mauricio Barreto, MD
Children’s National Hospital
Washington, DC
Creatinine-Based Estimating Equations for GFR Outperform Cystatin C-Based Equations in Adults with Sickle Cell Disease

Nosakhare Paul Ilerhunmwuwa, MBBS,MSc
Brookdale University Hospital and Medical Center
Brooklyn, NY
Factors Associated with Severity and Poor Outcomes in COVID-19 Infection in Patients with Sickle Cell Disease: A Single-Institution Experience

Sacha Choupa
Meharry Medical College School of Medicine
Nashville, TN
Risk Factors for Thrombosis in Pregnant People with Sickle Cell Disease: A Multinational Study

Yaa Ofori-Marfoh, MSc,BS
Rush Medical College of Rush University
Durham, NC
Experiences of Menopause in Women with Sickle Cell Disease

back to top

Simulcast of Anouncement of Awards and Plenary Scientific Session (for in-person participants)

Sunday, December 10, 2023, 1:30 p.m. - 4:00 p.m.
Marriott Marquis San Diego Marina, San Diego Ballroom AB

back to top

Special Scientific Session on Race and Science: Bench to Bedside to the Community

“Race and Science: Bench to Bedside to the Community

Sunday, December 10, 2023, 9:30 a.m. - 11:00 a.m.
San Diego Convention Center, Hall A

Race is a prominent focus in academic health centers in the country, but what role do racial categories play in biomedical research or in the delivery of care to patients? Disparities in health care and disease outcomes exist, and there are racial groups who experience disproportionally worse outcomes and a shortened life expectancy. However, racial categories, as designed, represent social and biological factors that are not fully understood. How might we utilize race more appropriately – not to discriminate but to better understand the biology of disease while also delivering equitable care? This session is intended to serve as both the foundation and the beginning of a conversation on these critical issues.?Each speaker will present different perspectives on how and where to begin this discussion.  

Dr. Alisa Wolberg will discuss the role of the basic scientist and how the concepts of diversity, equity, and inclusion may be considered when designing investigations and experiments that will lead to data that is broadly generalizable and applicable.  

Dr. Saad Usmani will address the next step, regarding moving basic science to the bedside and discussing strategies that?assure clinical trials with novel therapies are inclusive and diverse.  

Ms. Shonta Chambers will provide the patient perspective and will highlight how best to engage with community and national organizations to strengthen the relationship between patients and the health care team to achieve the goal of equitable access to care and innovation. 

Dr. Nicole Gormley will present on the US Food and Drug Administration’s guidance on “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials.” She will highlight the potential impact that regulatory agencies may have on clinical trial development.? 

Co-Chairs:

Elizabeta Nemeth, PhD
David Geffen School of Medicine At UCLA
Los Angeles, CA

Alison R. Walker, MD, MPH, MBA
H.Lee Moffitt Cancer Center and Research Institute
Tampa, FL

Nadine J Barrett, PhD,MS,MA
Duke University School of Medicine
Durham, NC

Speakers:

Shonta Chambers, MSW
Patient Advocate Foundation
Hampton, VA
Community and Patient Advocate Perspective

Saad Z Usmani, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Clinical Trial Perspective

Nicole Gormley, MD
US Food and Drug Administration
Silver Spring, MD
Regulatory Perspective

Alisa S Wolberg, PhD
University of North Carolina at Chapel Hill
Chapel Hill, NC
Basic Science Perspective

back to top

Special Session on Sickle Cell Disease Centers

Looking for Money in All the “Right” Places for Sickle Cell

Saturday, December 9, 2023, 9:30 a.m. - 11:00 a.m.
San Diego Convention Center, Hall A

As care for people with sickle cell disease gets more complex and there are more treatment options available, it is imperative that all people with SCD receive care through a sickle cell center.

Over the last several years, ASH has developed a workshop and blueprint for the creation of Sickle Cell Disease Centers. Despite their necessity, it can still be difficult to ensure funding for these centers. This session will focus on alternative ways to supplement funding for sickle cell disease centers.

Co-Chairs:

Payal Desai, MD
Atrium Health
Charlotte, NC

Julie Kanter, MD
University of Alabama At Birmingham
Birmingham, AL

Speakers:

Sophie Lanzkron
Johns Hopkins Medical Institute
Baltimore, MD
Maximizing Revenue from an Infusion Center

Julie Kanter, MD
University of Alabama At Birmingham
Birmingham, AL
Partnering With Your Hospital On 340B

Alexis Kristine Leonard, MD
St. Jude Children's Research Hospital
Memphis, TN
Getting Ready to Provide Genetic Therapies

back to top

Special Symposium on Quality - Identifying and Addressing Underuse in Hematologic Care

Saturday, December 9, 2023, 2:00 p.m. - 3:30 p.m.
San Diego Convention Center, Room 11

Underuse of appropriate tests, procedures, and therapies is a significant issue in hematology, resulting in negative outcomes for both individuals and populations.  This special symposium will identify three key areas of underuse in hematology and provide recommendations for addressing them:

• Retrieval of inferior vena cava (IVC) filters
• Use of hydroxyurea in patients with sickle cell disease
• Patient education prior to anticoagulation

This session will encourage all stakeholders to incorporate strategies for identifying and addressing underuse into their quality improvement efforts.

Co-Chairs:

Ming Y Lim, MBBChir
University of Utah
Salt Lake City, UT

Jacob Cogan, MD
University of Minnesota
Minneapolis, MN

Speakers:

Geoffrey D. Barnes, MD, MSc
University of Michigan
Ann Arbor, MI
IVC Filter Retrieval

Alexandra Power-Hays, MD
University of Cincinnati College of Medicine
Cincinnati, OH
Hydroxyurea in Sickle Cell Disease

Allison E. Burnett, PharmD
University of New Mexico Health Sciences Center
Albquerque, NM
Patient Education Prior to Anticoagulation

back to top

Systems-Based Hematology Education and Networking Session: Hematology E-Consultation

Sunday, December 10, 2023, 4:30 p.m. - 6:30 p.m.
San Diego Convention Center, Room 30

This session offers an opportunity for attendees to learn about systems-based hematology (SBH) and to meet other hematologists interested in this novel career-path. The first hour focuses on highlighting examples of systems-based approaches and systems-level interventions in hematologic care. The second hour transitions to networking with drinks and hors d'oeuvres.

This year's speakers include Dr. Sandhya Panch, MD, MPH, who will discuss initiation, resource allocation, and optimal work flows for hematology e-consultation, and Dr. Surbhi Shah, MD, who will review lessons learned in the development and management of hematology e-consultation services.

Chair:

Marc Stuart Zumberg, MD
University of Florida
Gainesville, FL

Speakers:

Sandhya R Panch, MD
Fred Hutchinson Cancer Center
Mercer Island, WA
Start up, Resource Allocation, Insurance, and Work Flow for Hematology E-Consultation

Surbhi Shah, MD
Mayo Clinic
Scottsdale, AZ
Lessons Learned in Hematology E-Consultation: Advantages, Disadvantages, and Applicability to Other Academic Centers and Smaller Institutions

back to top

Training Program Directors Workshop (for in-person participants)

Friday, December 8, 2023, 9:00 a.m. - 12:00 p.m.
Hilton San Diego Bayfront, Indigo 204

The Training Program Directors Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training to share lessons learned, best practices, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network.

Chair:

Sanjay Mohan, MD, MSCI
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Nashville, TN

Speakers:

Tamara J. Dunn, MD
Stanford University
Stanford, CA
Diversity, Equity, and Inclusion Considerations & Recruitment

Martha Arellano
Emory University School of Medicine
Atlanta, GA
Diversity, Equity, and Inclusion Considerations & Recruitment

Sanjay Mohan, MD, MSCI
Vanderbilt University Medical Center
Nashville, TN
Combatting Virtual Learning

Gerald Hsu, MD,PhD
University of California, San Francisco
San Francisco, CA
Combatting Virtual Learning

Jessica M. Stempel, MD
Yale School of Medicine
New Haven, CT
Combatting the Stigma of Being an International Medical Graduate

Pallawi Torka, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Combatting the Stigma of Being an International Medical Graduate

back to top

Wake Up To DEI Networking Breakfast (for in-person participants)

Monday, December 11, 2023, 7:00 a.m. - 8:30 a.m.
Marriott Marquis San Diego Marina, Marina Ballroom

This is a community-building and networking event for members that fall within the diversity, equity, and inclusion (DEI) umbrella to gather and get to know each other across the varying and intersectional communities. The event will include remarks from a member of the ASH Committee on Diversity, Equity, and Inclusion. 

The event is hosted by the ASH DEI Programs Subcommittee and aims to create space for ASH DEI communities and allies and, where possible, identify opportunities to learn more about the experiences and needs of these communities to allow ASH to have a greater impact in its DEI efforts. 

back to top

Women In Hematology Networking Event (for in-person participants)

Women in Leadership Panel

Monday, December 11, 2023, 7:30 p.m. - 9:30 p.m.
Manchester Grand Hyatt San Diego, Coronado Ballroom & Terrace

This popular annual reception will provide a space where all can gather in an informal environment and connect with peers and potential mentors. The event will include a panel discussion focused on leadership through a gender and career development lens as well as ample networking opportunities.

Moderators:

Ariela L. Marshall, MD
University of Minnesota
Minneapolis, MN

Tamara J. Dunn, MD
Stanford University
Atherton, CA

Panelists:

Konstanze Döhner
University Hospital of Ulm
Ulm, Germany

Ifeyinwa Osunkwo, MD, MPH
Ify Osunkwo MD, MPH, formerly Director SCD Enterprise Atrium Health; Currently Chief Patient Officer / SVP Forma therapeutics
Colts Neck, MA

Alexis A. Thompson, MD, MPH
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA